Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Expert Review of Clinical Pharmacology Volume 13, 2020 - Issue 10

Submit an article Journal homepage

Open access

4,526

Views

CrossRef citations to date

Altmetric

Drug Profile

Antibody–drug conjugates for previously treated aggressive lymphomas: focus on polatuzumab vedotin

J. M. Burkea The US Oncology Network, Rocky Mountain Cancer Centers, Aurora, CO, USAView further author information

F. Morschhauserb Centre Hospitalier Régional Universitaire De Lille, Université Lille, Lille, FranceView further author information

D. Andorskyc The US Oncology Network, Rocky Mountain Cancer Centers, Boulder, CO, USAView further author information

C. Leed Genentech, South San Francisco, CA, USAView further author information

J. P. Sharmane The US Oncology Network, Willamette Valley Cancer Institute, Springfield, OR, USACorrespondence[email protected]
View further author information

Pages 1073-1083 | Received 03 Jul 2020, Accepted 17 Sep 2020, Published online: 05 Oct 2020

Cite this article
https://doi.org/10.1080/17512433.2020.1826303
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (5)

Yu Jun Lim, Pei Sze Clarissa Lau, Shi Xuan Low, Shong Li Ng, Min Yee Ong, Huey Ming Pang, Zheng Yang Lee, Hui Yin Yow, Sharina Binti Hamzah, Renukha Sellappans & Jhi Biau Foo. (2023) How Far Have We Developed Antibody–Drug Conjugate for the Treatment of Cancer?. Drugs and Drug Candidates 2:2, pages 377-421.
Crossref

Giulia Pander, Philipp Uhl, Nikos Kühl, Uwe Haberkorn, Jan Anderl & Walter Mier. (2022) Antibody–drug conjugates: What drives their progress?. Drug Discovery Today 27:10, pages 103311.
Crossref

Claudia Ceci, Pedro Miguel Lacal & Grazia Graziani. (2022) Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential. Pharmacology & Therapeutics 236, pages 108106.
Crossref

Yurou Chu, Xiangxiang Zhou & Xin Wang. (2021) Antibody-drug conjugates for the treatment of lymphoma: clinical advances and latest progress. Journal of Hematology & Oncology 14:1.
Crossref

Michael A. Firer & Galia Luboshits. (2021) Antibody‐Drug‐Conjugate Therapy for Hematological Cancers: Matching Cell Biology with Clinical Benefit. Advanced Functional Materials 31:44, pages 2100032.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references